Research programme: amylin receptor agonists - Structure Therapeutics
Alternative Names: ACCG-0184Latest Information Update: 23 May 2024
At a glance
- Originator Structure Therapeutics
- Class Obesity therapies; Small molecules
- Mechanism of Action Amylin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Obesity